Amarillo Biosciences to Support Western Australian Government Sponsored Human Influenza Clinical Trial in Perth, Australia

AMARILLO, TX--(Marketwire - August 01, 2008) - Amarillo Biosciences, Inc. (OTCBB: AMAR) today announced that it has agreed to provide interferon lozenges and other support for Western Australia's government (Department of Health) sponsored human influenza clinical trial led by Dr. Manfred Beilharz, Microbiology and Immunology, School of Biomedical, Bimolecular and Chemical Sciences, Faculty of Life and Physical Sciences, The University of Western Australia.